av/ocuphire-pharma--big.svg

COM:OCUPHIRE

Opus Genetics

  • Stock

USD

Last Close

1.33

23/10 20:00

Market Cap

42.77M

Beta: -

Volume Today

675.97K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
-9.50M
-
-18.52M
94.98%
-14.38M
22.34%
-25.29M
-
-14.37M
43.20%
-6.17M
57.07%
-24.62M
299.09%
-56.69M
130.27%
17.89M
131.55%
-9.99M
155.83%
depreciation and amortization
37.13K
-
38.55K
3.82%
58.37K
51.41%
94.37K
-
87.46K
7.32%
3K
96.57%
8K
166.67%
4K
50%
4K
0%
6K
50%
deferred income tax
-81.92K
-
-1.53M
1,762.17%
-202.03K
86.76%
-1.35M
-
81.38K
106.02%
499K
513.20%
-1.50M
400%
33.61M
2,345.16%
77.00K
-
stock based compensation
565.43K
-
608.79K
7.67%
1.04M
70.45%
1.04M
-
1.23M
17.64%
308K
74.93%
1.51M
388.96%
1.91M
27.09%
1.81M
5.59%
3.51M
94.24%
change in working capital
81.92K
-
1.53M
1,762.17%
202.03K
86.76%
1.35M
-
-81.38K
106.02%
357K
538.70%
1.15M
221.01%
181K
84.21%
-5.55M
3,169.06%
4.08M
173.38%
accounts receivables
-1.30M
-
2.52M
293.91%
inventory
-1
-
accounts payables
81.92K
-
1.53M
1,762.17%
202.03K
86.76%
1.35M
-
-81.38K
106.02%
-168K
106.45%
792K
571.43%
381K
51.89%
-515K
235.17%
1.08M
310.10%
other working capital
-81.92K
-
-1.53M
1,762.17%
-202.03K
86.76%
-1.35M
-
81.38K
106.02%
525K
545.15%
354K
32.57%
-200K
156.50%
-3.74M
1,771%
477K
112.75%
other non cash items
912.01K
-
6.83M
649.23%
-4.06M
159.47%
8.74M
-
-5.79M
166.23%
1.41M
124.35%
16.66M
1,082.40%
1.61M
90.31%
170K
89.47%
1.21M
608.82%
net cash provided by operating activities
-7.98M
-
-11.04M
38.28%
-17.35M
57.16%
-13.23M
23.77%
-15.42M
16.58%
-18.84M
22.17%
-3.59M
80.93%
-6.80M
89.17%
-19.37M
184.98%
14.31M
173.90%
-1.11M
107.77%
investments in property plant and equipment
-25K
-
-1.48M
5,800%
-100K
93.22%
acquisitions net
purchases of investments
-26.08M
-
-7.91M
69.67%
-21.02M
-
-8.89M
-
sales maturities of investments
other investing activites
845.52K
-
3.41M
303.88%
17.46M
411.37%
4.48M
74.32%
11.64M
159.70%
11.91M
2.29%
8.89M
25.38%
2.01M
77.34%
net cash used for investing activites
845.52K
-
-22.66M
2,780.12%
9.55M
142.16%
4.48M
53.07%
-9.37M
309.03%
11.91M
227.08%
-25K
100.21%
539K
2,256%
-100K
118.55%
debt repayment
-4.70M
-
-2.19M
53.51%
-108K
95.06%
-538K
398.15%
common stock issued
10.04M
-
18.63M
85.58%
7.44M
60.07%
16.68M
-
6.87M
58.80%
7.65M
11.36%
21.15M
176.33%
28.49M
34.71%
4.43M
84.46%
8.98M
102.78%
common stock repurchased
dividends paid
other financing activites
2.30M
-
6.21M
169.87%
730.94K
88.22%
10.12M
1,284.82%
5.43M
46.34%
-100K
101.84%
1.75M
1,854.17%
2.16M
22.96%
-778K
136.07%
-104K
86.63%
net cash used provided by financing activities
12.34M
-
24.84M
101.29%
8.17M
67.11%
10.12M
23.88%
22.11M
118.46%
6.77M
69.37%
4.70M
30.55%
21.12M
348.98%
27.61M
30.71%
3.79M
86.29%
8.98M
137.16%
effect of forex changes on cash
net change in cash
5.20M
-
-8.86M
270.37%
373.19K
104.21%
1.38M
269.52%
-2.68M
294.29%
-154.85K
94.22%
1.09M
801.31%
14.86M
1,268.51%
8.13M
45.26%
18.10M
122.50%
7.87M
56.54%
cash at beginning of period
13.49M
-
18.69M
38.57%
9.83M
47.42%
11.58M
-
8.90M
23.14%
451K
94.93%
1.54M
240.80%
16.40M
966.95%
24.53M
49.61%
42.63M
73.78%
cash at end of period
18.69M
-
9.83M
47.42%
10.20M
3.80%
1.38M
86.48%
8.90M
545.32%
8.74M
1.74%
1.54M
82.42%
16.40M
966.95%
24.53M
49.61%
42.63M
73.78%
50.50M
18.45%
operating cash flow
-7.98M
-
-11.04M
38.28%
-17.35M
57.16%
-13.23M
23.77%
-15.42M
16.58%
-18.84M
22.17%
-3.59M
80.93%
-6.80M
89.17%
-19.37M
184.98%
14.31M
173.90%
-1.11M
107.77%
capital expenditure
-25K
-
-1.48M
5,800%
-100K
93.22%
free cash flow
-7.98M
-
-11.04M
38.28%
-17.35M
57.16%
-13.23M
23.77%
-15.42M
16.58%
-18.84M
22.17%
-3.62M
80.79%
-8.27M
128.63%
-19.47M
135.37%
14.31M
173.52%
-1.11M
107.77%

All numbers in USD (except ratios and percentages)